| Cash Flow | 2026-03-31 |
|---|---|
| Net loss from continuing operations | -262,908 |
| Depreciation of property, plant and equipment | 19,026 |
| Amortization of intangible assets | 17,447 |
| Share-based compensation | 4,266 |
| Loss on asset impairment and restructuring | -58,055 |
| Income tax expense | 23 |
| Non-cash fair value adjustments and charges related to settlement of long-term debt | 72,907 |
| Amounts receivable | -25,685 |
| Inventory | -3,710 |
| Prepaid expenses and other assets | 4,367 |
| Accounts payable and accrued liabilities | -4,353 |
| Other, including non-cash foreign currency | -6,703 |
| Net cash used in operating activities - continuing operations | -63,806 |
| Net cash used in operating activities - discontinued operations | 0 |
| Net cash used in operating activities | -63,806 |
| Purchases of and deposits on property, plant and equipment | 5,333 |
| Purchases of intangible assets | 620 |
| Proceeds on sale of property, plant and equipment | 5 |
| Redemption of short-term investments | -19,001 |
| Net cash outflow on sale or deconsolidation of subsidiaries | 0 |
| Net cash outflow on acquisition of subsidiaries | 41,536 |
| Net cash inflow on loan receivable | 153 |
| Investment in other financial assets | 0 |
| Other investing activities | -6,981 |
| Net cash provided by (used in) investing activities - continuing operations | -21,349 |
| Net cash provided by investing activities - discontinued operations | 0 |
| Net cash provided by (used in) investing activities | -21,349 |
| Proceeds from issuance of common shares and warrants | 374,171 |
| Proceeds from exercise of stock options | 0 |
| Proceeds from exercise of warrants | 0 |
| Issuance of long-term debt and convertible debentures | 207,990 |
| Repayment of long-term debt | 221,508 |
| Debt issuance and extinguishment costs | 11,039 |
| Other financing activities | -17,205 |
| Net cash provided by (used in) financing activities | 332,409 |
| Effect of exchange rate changes on cash and cash equivalents | 3,618 |
| Net increase/(decrease) in cash and cash equivalents | 250,872 |
| Cash and cash equivalents, beginning of period | 113,811 |
| Cash and cash equivalents, end of period | 364,683 |
Canopy Growth Corp (CGC)
Canopy Growth Corp (CGC)